GLPwatch
Trials (2167)
Page 32 of 37.
- A Research Study Looking at How Semaglutide Works in People With Type 2 Diabetes in The Netherlands, as Part of Local Clinical Practice (SURE NETHERLANDS)
- GLP-1R Agonist Treatment for Opioid Use Disorder
- Study to Assess the Efficacy of Liraglutide in Patients With Type 2 Diabetes Mellitus
- Randomized Control Trial of Sleeve Gastrectomy With Tirzepatide in Maximizing Weight Loss
- Dual Action of Liraglutide and Insulin Degludec in Type 2 Diabetes: A Trial Comparing the Efficacy and Safety of Insulin Degludec/Liraglutide, Insulin Degludec and Liraglutide in Subjects With Type 2 Diabetes
- Comparative Effectiveness of Tirzepatide vs Semaglutide in Participants With Type 2 Diabetes and Heart Failure With Preserved Ejection Fraction
- Exendin-4 as a Treatment for Parkinson's Disease - Pilot Study
- JOULE - Metabolic Adaptation to Weight Loss in Response to a Behavioural Lifestyle Program With or Without Semaglutide in Adolescents With Obesity
- A Trial Comparing Insulin Degludec/Liraglutide and Insulin Degludec in Combination With Metformin in Chinese Subjects With Type 2 Diabetes Mellitus Inadequately Controlled With Basal Insulin Therapy and Metformin With or Without One Other Oral Antidiabetic Drug (OAD)
- A Study in Healthy People or Otherwise Healthy With Overweight or Obesity to Compare 2 Formulations of Survodutide Given in Different Ways, Either as a Pre-filled Syringe or a Pen-like Injector
- Multi-parametric Imaging of the Knee in Obese Patients With Knee Osteoarthritis; Weight Maintenance
- A Study of the Glucodynamic Effects of Dulaglutide (LY2189265) in Japanese Participants With Type 2 Diabetes
- Subcutaneous Semaglutide in Systemic Scleroderma
- Safety and Tolerability of Insulin Degludec/Liraglutide (A3) in Healthy Subjects
- Effects of Tirzepatide on Blood, Imaging and Breast Tissue Biomarkers
- Effect of Liraglutide on Fatty Liver Content and Lipoprotein Metabolism
- Efficacy, Safety, and Tolerability of CS0159 Combined With Semaglutide in MAFLD Patients With Obesity and T2DM
- The Effects of Exenatide, a GLP-1 Agonist, on Alcohol Self-Administration in Heavy Drinkers
- Adiponectin in Patients With Metabolic Disorders
- A Research Study to Look at How Insulin 287 and Semaglutide Work in the Body of People With Type 2 Diabetes When Taken Alone or Together
- Effect of Liraglutide (Victoza) on Inflammation in Human Adipose Tissue and Blood
- A Phase 2a Study of ALN-PNP With and Without a GLP1R Agonist in Adult Patients With Homozygous PNPLA3-Related MASLD
- The Effect of Retatrutide Once Weekly on Cardiovascular Outcomes and Kidney Outcomes in Adults Living With Obesity (TRIUMPH-Outcomes)
- A Phase I Study of LY3502970 in Healthy Participants
- A Safety Study to Assess the Effects of Therapeutic and Supratherapeutic Exenatide Concentrations on QT Interval in Healthy Subjects
- A Research Study Looking at the Effect of Semaglutide on the Immune System and Other Biological Processes in People With Alzheimer's Disease
- A Study of Two Different Formulations of LY3502970 in Healthy Participants
- A Research Study to Understand How Oral Semaglutide Works in People With Type 2 Diabetes in India
- A Study of LY3437943 in Healthy Participants With a High Body Mass Index
- Comparison of Exenatide and Metformin Monotherapy in Overweight/Obese Patients With Newly Diagnosed Type 2 Diabetes
- Roflumilast Plus Alogliptin Proof-of-Mechanism Study in Type2 Diabetes
- Comparison of Liraglutide Inhaled Into the Lungs Compared to Liraglutide Injected Under the Skin in Healthy Male Volunteers
- A Research Study to Compare Blood Levels of Cagrilintide After Multiple Doses of Different Versions of Cagrilintide in Adults With Overweight or Obesity
- Endoscopic Ultrasound Guided Gastric Botulinum Toxin Injections Versus Glucagon Like Peptide 1 Receptor Agonist in Weight Loss
- Effect of Liraglutide on Clock Genes
- A Study of Tirzepatide in Participants With Type 2 Diabetes Mellitus
- A Research Study to Look at How Semaglutide Affects Gastric Emptying in People With Obesity
- GLP-1's Effect on Cardiac Parameters and Mesenteric Blood Flow
- Treatment of Diabetic Neuropathy With Liraglutide
- Metformin vs Metformin Combined With GLP-1RA (Glucagon-like Peptide 1 Receptor Agonist) on Overweight/Obese PCOS Patients
- Impact of Semaglutide on Tobacco Use and Related Health Behaviors
- The Effect of Liraglutide on Body Weight in Obese Subjects Without Diabetes
- Can Two Dietary Interventions Maintain Weight Loss for 12 Months After GLP-1 Therapy in Adults With Overweight/Obesity?
- Efficacy and Safety of Metformin and Liraglutide in Obese Subjects With Type 2 Diabetes Previously Treated With an Oral Hypoglycemic Agent
- A Clinical Trial Comparing Semaglutide in Healthy People Who Eat and Take the Medicine at Different Times
- A Phase III Clinical Study to Evaluate the Efficacy and Safety of GZR18 Injection in Adult Type 2 Diabetes Mellitus
- Study of Liraglutide (A Weight Loss Drug) in High Risk Obese Participants With Cognitive and Memory Issues
- Study of Liraglutide in Individuals With Type 2 Diabetes Using Insulin
- The Effect of Liraglutide on Bone Turnover, Bone Mass and Bone Cell Function
- Effects of GLP-1RA on Body Weight, Metabolism and Fat Distribution in Overweight/Obese Patients With Type 2 Diabetes Mellitus
- Off-Label Medications for Alcohol Use Disorder Among Patients With HIV: Pilot Study 3 Semaglutide
- Effect on Weight Loss of Exenatide Versus Placebo
- A Study to Compare the Concentrations of LY2189265 After Different Methods of Administration to Healthy Volunteers.
- Effect of Liraglutide Compared to Glimepiride on Appetite in Subjects With Type 2 Diabetes
- Impact of Antiobesity Medications on Appetite and Appetite-related Hormones and Metabolites.
- Comparison Between GLP 1 Analogues and DPP 4 Inhibitors in Type 1 Diabetes Mellitus
- A Master Protocol for Orforglipron (LY3502970) in Participants With Obesity or Overweight With and Without Type 2 Diabetes
- Semaglutide in Women With Polycystic Ovary Syndrome and Obesity
- Observational Study of Interstitial Glucose Monitoring With Continuous Glucose Monitoring to Track Patients Treated With Exenatide
- Exenatide for the Treatment of Weight Gain Associated With Olanzapine in Obese Adults